Nexstim Past Earnings Performance

Past criteria checks 0/6

Nexstim has been growing earnings at an average annual rate of 41.9%, while the Medical Equipment industry saw earnings growing at 5% annually. Revenues have been growing at an average rate of 25.7% per year.

Key information

41.9%

Earnings growth rate

93.7%

EPS growth rate

Medical Equipment Industry Growth28.7%
Revenue growth rate25.7%
Return on equity-46.8%
Net Margin-15.5%
Next Earnings Update16 Aug 2024

Recent past performance updates

Nexstim's (HEL:NXTMH) Promising Earnings May Rest On Soft Foundations

Aug 20
Nexstim's (HEL:NXTMH) Promising Earnings May Rest On Soft Foundations

Recent updates

Is Now The Time To Look At Buying Nexstim Plc (HEL:NXTMH)?

Nov 17
Is Now The Time To Look At Buying Nexstim Plc (HEL:NXTMH)?

Nexstim's (HEL:NXTMH) Promising Earnings May Rest On Soft Foundations

Aug 20
Nexstim's (HEL:NXTMH) Promising Earnings May Rest On Soft Foundations

At €4.73, Is Nexstim Plc (HEL:NXTMH) Worth Looking At Closely?

Aug 15
At €4.73, Is Nexstim Plc (HEL:NXTMH) Worth Looking At Closely?

Is Nexstim (HEL:NXTMH) A Risky Investment?

Jun 14
Is Nexstim (HEL:NXTMH) A Risky Investment?

Nexstim (HEL:NXTMH) Has Debt But No Earnings; Should You Worry?

Dec 02
Nexstim (HEL:NXTMH) Has Debt But No Earnings; Should You Worry?

Is Nexstim (HEL:NXTMH) Using Debt In A Risky Way?

Aug 18
Is Nexstim (HEL:NXTMH) Using Debt In A Risky Way?

Revenue & Expenses Breakdown
Beta

How Nexstim makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

HLSE:NXTMH Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 239-150
30 Sep 238-250
30 Jun 236-350
31 Mar 239-150
31 Dec 2211150
30 Sep 2211250
30 Jun 2212350
31 Mar 2210150
31 Dec 218-150
30 Sep 217-250
30 Jun 216-440
31 Mar 215-440
31 Dec 204-440
30 Sep 204-440
30 Jun 204-450
31 Mar 204-650
31 Dec 193-750
30 Sep 193-750
30 Jun 193-750
31 Mar 193-750
31 Dec 183-640
30 Sep 183-640
30 Jun 183-640
31 Mar 183-740
31 Dec 173-740
30 Sep 173-740
30 Jun 173-640
31 Mar 173-640
31 Dec 163-740
30 Sep 163-840
30 Jun 163-940
31 Mar 163-1040
31 Dec 153-1040
30 Sep 153-1040
30 Jun 153-1040
31 Mar 152-1040
31 Dec 142-1040
30 Sep 142-940
30 Jun 142-730
31 Mar 142-630
31 Dec 132-530

Quality Earnings: NXTMH is currently unprofitable.

Growing Profit Margin: NXTMH is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: NXTMH is unprofitable, but has reduced losses over the past 5 years at a rate of 41.9% per year.

Accelerating Growth: Unable to compare NXTMH's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: NXTMH is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (5.2%).


Return on Equity

High ROE: NXTMH has a negative Return on Equity (-46.8%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.